Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.2B |
| 3 |
Oracle
ORCL
|
+$945M |
| 4 |
Meta Platforms (Facebook)
META
|
+$913M |
| 5 |
JPMorgan Chase
JPM
|
+$901M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.64B |
| 2 |
Thermo Fisher Scientific
TMO
|
+$1.16B |
| 3 |
Qualcomm
QCOM
|
+$1.02B |
| 4 |
Tesla
TSLA
|
+$911M |
| 5 |
Mastercard
MA
|
+$837M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.54% |
| 2 | Healthcare | 13.79% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Financials | 10.34% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Nurix Therapeutics
NRIX
$2.65B
| $4.16M | ﹤0.01% |
416,613
-33,631
| -7% | -$343K |
|
2002
OFG Bancorp
OFG
$2.21B
| $4.07M | ﹤0.01% |
156,157
+21,043
| +16% | +$528K |
|
|
PDCO
2003
DELISTED
Patterson Companies, Inc.
PDCO
| $4.04M | ﹤0.01% |
121,603
+97,785
| +411% | +$2.7M |
|
2004
Design Therapeutics
DSGN
$876M
| $4.02M | ﹤0.01% |
637,770
-320,133
| -33% | -$1.96M |
|
2005
American States Water
AWR
$3.46B
| $4.01M | ﹤0.01% |
46,097
-51
| -0.1% | -$4.57K |
|
2006
Avantor
AVTR
$9.19B
| $4M | ﹤0.01% |
194,524
-288,281
| -60% | -$5.83M |
|
2007
F5
FFIV
$22.7B
| $3.99M | ﹤0.01% |
27,307
-117,910
| -81% | -$16.8M |
|
|
MPT
2008
Medical Properties Trust
MPT
$2.81B
| $3.99M | ﹤0.01% |
430,474
+279,257
| +185% | +$2.36M |
|
|
AVNS
2009
DELISTED
Avanos Medical
AVNS
| $3.98M | ﹤0.01% |
155,875
+22,585
| +17% | +$595K |
|
2010
Affirm
AFRM
$25.2B
| $3.97M | ﹤0.01% |
259,238
+246,768
| +1,979% | +$3.27M |
|
2011
Banco Bradesco
BBD
$36.7B
| $3.97M | ﹤0.01% |
1,146,872
+442,011
| +63% | +$1.37M |
|
2012
Viant Technology
DSP
$265M
| $3.95M | ﹤0.01% |
856,155
-1,095,103
| -56% | -$4.85M |
|
|
ZIMV
2013
DELISTED
ZimVie
ZIMV
| $3.94M | ﹤0.01% |
351,018
+63,129
| +22% | +$613K |
|
2014
Nomura Holdings
NMR
$29.1B
| $3.93M | ﹤0.01% |
1,025,844
+35,565
| +4% | +$132K |
|
2015
Graco
GGG
$13.5B
| $3.9M | ﹤0.01% |
45,213
+29,385
| +186% | +$2.28M |
|
2016
Park-Ohio Holdings
PKOH
$761M
| $3.9M | ﹤0.01% |
205,220
-694,625
| -77% | -$10.6M |
|
2017
iShares ESG MSCI USA Leaders ETF
SUSL
$1.21B
| $3.88M | ﹤0.01% |
50,119
+13,705
| +38% | +$1M |
|
2018
Fidelity Sustainable High Yield ETF
FSYD
$145M
| $3.86M | ﹤0.01% |
85,000
-20,000
| -19% | -$906K |
|
2019
Myers Industries
MYE
$1.29B
| $3.86M | ﹤0.01% |
198,564
-3,488
| -2% | -$68.5K |
|
2020
AXIS Capital
AXS
$7.55B
| $3.85M | ﹤0.01% |
71,547
+44,062
| +160% | +$2.41M |
|
2021
Vanguard Extended Market ETF
VXF
$31.9B
| $3.82M | ﹤0.01% |
25,679
+309
| +1% | +$43.3K |
|
|
AMNB
2022
DELISTED
American National Bankshares Inc
AMNB
| $3.82M | ﹤0.01% |
131,840
-1,495
| -1% | -$43K |
|
2023
Schwab US Dividend Equity ETF
SCHD
$106B
| $3.81M | ﹤0.01% |
157,218
+13,194
| +9% | +$315K |
|
2024
Cogent Biosciences
COGT
$7.24B
| $3.8M | ﹤0.01% |
321,260
+275,620
| +604% | +$3.16M |
|
|
LGF.A
2025
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $3.79M | ﹤0.01% |
429,618
+152,402
| +55% | +$1.6M |
|
Similar funds
Fidelity Investments's Q2 2023 Portfolio in Review
As of Q2 2023, Fidelity Investments held 5,715 positions worth $1.19T, up 9.1% from $1.09T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Fidelity Investments's Q2 2023 filing shows 467 new, 2,358 increased, 2,086 reduced and 337 closed positions. Its largest new stake was Crane Co: 6,604,359 shares worth $589M. The largest sale was NVIDIA, an estimated $1.64B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2023 buy was Crane Co: 6,604,359 shares worth $589M.
- Fidelity Investments added most to Microsoft in Q2 2023, an estimated $3B increase.
- Fidelity Investments's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $1.64B.
- Fidelity Investments fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $123M.
- Fidelity Investments's ten largest holdings make up 30% of its $1.19T portfolio in Q2 2023.
- Fidelity Investments opened 467 new positions and closed 337 in Q2 2023.
- Fidelity Investments's portfolio value rose 9.1% quarter-over-quarter to $1.19T.
Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.